Biopharmaceutical production of therapeutic proteins and monoclonal antibodies relies heavily on mammalian cell bioreactors. Bioreactors allow cell culture to be conducted in a way that maximizes cell productivity and growth. With years of experience, Shanghai Ritai is able to provide products that not only meet industry criteria for quality and safety but also allow customers to meet their production goals in a timely manner.
Copyright © 2026 by Shanghai Ritai Medicine Equipment Project Co., Ltd. - Privacy policy